Remarkably, although elevated, the levels of APRIL/TNFSF13, sCD30, sCD163, sTNF-R1, and sTNF-R2 were lower in COVID-19 than in pandemic influenza A(H1N1) patients. This evidence concerns the gene CD163 and COVID-19.